Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome

NCT02823145 is registered in ClinicalTrials.gov with Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. as lead sponsor.

NCT NCT02823145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02823145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome
Lead sponsor
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 8, 2016
Completion date
January 27, 2023
Enrollment
375 (actual)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

dravet syndrome